Pistoia Alliance AbVance: focus on advancing the state of the art in antibody complex modelling for drug discovery. Review on ‘Computational approaches to therapeutic antibody design’ submitted for publication.... See more...
Jake Dreier, Pistoia Alliance discusses the outcomes from our Blockchain Use Case Analysis workshop. The Blockchain Use Case Analysis Workshop on 12 March 2019 was an incredibly exciting experience... See more...
The HELM team is pleased to announce the publication of monomer guidelines for peptides. Monomers are the building blocks of bio-molecules and HELM adopters need to decide what... See more...
Three-day EU conference covering range of topics examines how technology is driving change in life sciences R&D and improving patients’ health London, 18th March, 2019 – The Pistoia... See more...
Project backed by major pharma will advance the Lab of the Future with proof of concept software to digitise experiment methods Boston, 25 February, 2019 – The Pistoia... See more...
Participants used the AI environment created by Elsevier’s Entellect platform in collaborative effort to discover potential treatments. New York, February 28, 2019 – Rare Disease Day – A unique non-profit and private partnership using... See more...
The HELM team is pleased to announce the publication of a set of HELM strings that can be used by external groups to test their HELM implementations. The... See more...
In 2016 the UK government amended the 1971 Misuse of Drugs Act (MoDA) and added a section designed to control the newer synthetic cannabinoids in increasing supply on the... See more...
The Pistoia Alliance Launches Next Phase of Blockchain Project to Develop Life Science R&D Use Cases Industry workshop will unlock blockchain’s potential in data identity, data integrity and... See more...
Tim Williams (find him on Linkedin) is the a co-lead of the PhUSE project “Clinical Trials Data as RDF”, an instructor for “Linked Data for Clinical Trials: A Hands-on... See more...
By clicking "Agree" you are agreeing to the following terms and conditions for the use of the UDM XML Schema definition.
This website intends to use cookies to improve the site and provide you with a better browsing experience. If you select "Continue" or continue to browse the site without customizing your choices, you agree to our use of cookies. Find out more in our Online Privacy Statement.